Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
Erkki Lathouwers(Janssen (Belgium)), Renato Maserati(Istituti di Ricovero e Cura a Carattere Scientifico), Magda Opsomer(Janssen (Belgium)), Massimo Galli(Luigi Sacco Hospital), Christine Katlama(Université Paris Cité), Markus Bickel, Adriano Lazzarin(Vita-Salute San Raffaele University), Andrea De Luca(Agostino Gemelli University Polyclinic), Johannes R. Bogner(Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation), Marina B. Klein(Royal Victoria Regional Health Centre), Sandra De Meyer(Janssen (Belgium)), Jacques Reynes(Centre Hospitalier Universitaire de Montpellier), Andrea Antinori(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), John Jezorwski(Janssen (United States)), Erika Van Landuyt(Janssen (Belgium)), Christoph D. Spinner(TUM Klinikum), El Ghazi Mohsine(Janssen (Belgium)), Heiko Jessen(Praxis (United States)), Francesco Castelli(University of Brescia), Bryan Baugh(Brigham and Women's Hospital), Yazdan Yazdanpanah(Inserm), Gerd Faetkenheuer(Janssen (Belgium)), Éric Florence(Instituut voor Tropische Geneeskunde), Kimberley Brown(Janssen (Belgium)), Linos Vandekerckhove(Ghent University Hospital), Daniel Murphy(Janssen (Belgium)), Antonio Chirianni(Université Ouaga II), Franco Maggiolo(Ospedale Papa Giovanni XXIII), Jason Brunetta(Maple Leaf Medical Clinic), Eric Wong(Austin Health), Isabelle Poizot‐Martin(Hôpital Sainte-Marguerite), F. Ajana, D. Rey(Janssen (Belgium)), W. Kern(University of Lübeck), Keikawus Arastéh(Auguste-Viktoria-Klinik), HJ Stellbrink, Albrecht Stoehr, Anita Rachlis(University of Toronto), François Raffi, Anne Ghys(Janssen (Belgium)), J Rockstroh(Janssen (United States)), PM Girard(Sorbonne Université), L Cotte(Janssen (Belgium)), J-M Molina, S De Wit(Janssen (Belgium)), B Vandercam(Janssen (United States)), E Teicher(Janssen (Belgium)), Sharon Walmsley(University Health Network), S Esser(Janssen (Belgium)), Antonio Di Biagio
Cited by 14
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k